×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ETNB – 89bio, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ETNB
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/19
04:05 pm
etnb
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
High
Report
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/14
05:49 am
etnb
89bio, Inc. (NASDAQ: ETNB) was upgraded by analysts at Raymond James to a "strong-buy" rating.
Low
Report
89bio, Inc. (NASDAQ: ETNB) was upgraded by analysts at Raymond James to a "strong-buy" rating.
12/4
01:07 pm
etnb
Why Is 89bio, Inc. (ETNB) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? [Yahoo! Finance]
Medium
Report
Why Is 89bio, Inc. (ETNB) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? [Yahoo! Finance]
11/29
01:35 pm
etnb
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Neutral
Report
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
11/29
01:30 pm
etnb
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Neutral
Report
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/26
04:14 pm
etnb
89bio to Participate in the 7th Annual Evercore HealthCONx Conference [Yahoo! Finance]
Low
Report
89bio to Participate in the 7th Annual Evercore HealthCONx Conference [Yahoo! Finance]
11/26
04:05 pm
etnb
89bio to Participate in the 7th Annual Evercore HealthCONx Conference
Low
Report
89bio to Participate in the 7th Annual Evercore HealthCONx Conference
11/15
08:10 am
etnb
89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting® 2024 [Yahoo! Finance]
Medium
Report
89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting® 2024 [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/23
04:41 pm
etnb
Form SCHEDULE 13G 89bio, Inc. Filed by: Deep Track Capital, LP
Low
Report
Form SCHEDULE 13G 89bio, Inc. Filed by: Deep Track Capital, LP
12/16
06:21 am
etnb
Form 4 89bio, Inc. For: Dec 12 Filed by: Mansbach Harry H
Low
Report
Form 4 89bio, Inc. For: Dec 12 Filed by: Mansbach Harry H
12/16
06:15 am
etnb
Form 4 89bio, Inc. For: Dec 12 Filed by: Martins Ryan
Low
Report
Form 4 89bio, Inc. For: Dec 12 Filed by: Martins Ryan
12/16
06:15 am
etnb
Form 4 89bio, Inc. For: Dec 12 Filed by: Le-Nguyen Quoc
Low
Report
Form 4 89bio, Inc. For: Dec 12 Filed by: Le-Nguyen Quoc
12/16
06:12 am
etnb
Form 8-K 89bio, Inc. For: Dec 12
Low
Report
Form 8-K 89bio, Inc. For: Dec 12
12/10
06:03 am
etnb
Form 4 89bio, Inc. For: Dec 06 Filed by: PALEKAR ROHAN
Low
Report
Form 4 89bio, Inc. For: Dec 06 Filed by: PALEKAR ROHAN
12/9
06:02 am
etnb
Form 4 89bio, Inc. For: Dec 05 Filed by: McWherter Charles
Low
Report
Form 4 89bio, Inc. For: Dec 05 Filed by: McWherter Charles
11/25
06:15 am
etnb
Form 4 89bio, Inc. For: Nov 22 Filed by: PALEKAR ROHAN
Neutral
Report
Form 4 89bio, Inc. For: Nov 22 Filed by: PALEKAR ROHAN
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/15
Form 8-K 89bio, Inc. For: Nov 13
16.7%
3/18 Q4/2019 12/31/2019 EPS 2.580 ZacksConsensus -0.810 ActVsEst 3.390 - Beat 13.1%
11/13 Form 4 89bio, Inc. For: Nov 11 Filed by: Kolchinsky Peter 12.9%
4/23 Form 8-K 89bio, Inc. For: Apr 17 10.9%
11/25 Form SC 13G 89bio, Inc. Filed by: Venrock Healthcare Capital Partners II, L.P. 9.0%
2/21 89bio to Present at the SVB Leerink 9th Annual Global Healthcare Conference 7.7%
3/26 Form 8-K 89bio, Inc. For: Mar 23 7.6%
2/14 Form SC 13G 89bio, Inc. Filed by: Nussbaum Ran 5.5%
11/8 Form S-1MEF 89bio, Inc. 4.0%
11/12 Form 424B4 89bio, Inc. 3.8%
3/18 Q4/2019 12/31/2019 EPS 2.580 ZacksConsensus -0.810 ActVsEst 3.390 - Beat 13.1%
11/13 Form 4 89bio, Inc. For: Nov 11 Filed by: Kolchinsky Peter 12.9%
4/23 Form 8-K 89bio, Inc. For: Apr 17 10.9%
11/25 Form SC 13G 89bio, Inc. Filed by: Venrock Healthcare Capital Partners II, L.P. 9.0%
2/21 89bio to Present at the SVB Leerink 9th Annual Global Healthcare Conference 7.7%
3/26 Form 8-K 89bio, Inc. For: Mar 23 7.6%
2/14 Form SC 13G 89bio, Inc. Filed by: Nussbaum Ran 5.5%
11/8 Form S-1MEF 89bio, Inc. 4.0%
11/12 Form 424B4 89bio, Inc. 3.8%
TOP News Decliners
12/18
Form 10-Q 89bio, Inc. For: Sep 30
-14.9%
4/29 89bio (NASDAQ: ETNB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $28.00 price target on the stock. -9.5%
12/9 89bio (NASDAQ: ETNB) is now covered by analysts at Bank of America Corp. They set a "neutral" rating on the stock. -7.7%
11/12 89Bio debuts IPO [Reuters] -5.0%
12/31 Form 8-K 89bio, Inc. For: Dec 24 -4.5%
4/7 89bio (NASDAQ: ETNB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $24.00 price target on the stock. -4.2%
4/23 89bio (NASDAQ: ETNB) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -3.8%
2/19 Form 4 89bio, Inc. For: Feb 14 Filed by: PALEKAR ROHAN -3.7%
11/21 Form SC 13D 89bio, Inc. Filed by: Longitude Capital Partners III, LLC -2.3%
4/7 89bio (NASDAQ: ETNB) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -2.1%
4/29 89bio (NASDAQ: ETNB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $28.00 price target on the stock. -9.5%
12/9 89bio (NASDAQ: ETNB) is now covered by analysts at Bank of America Corp. They set a "neutral" rating on the stock. -7.7%
11/12 89Bio debuts IPO [Reuters] -5.0%
12/31 Form 8-K 89bio, Inc. For: Dec 24 -4.5%
4/7 89bio (NASDAQ: ETNB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $24.00 price target on the stock. -4.2%
4/23 89bio (NASDAQ: ETNB) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -3.8%
2/19 Form 4 89bio, Inc. For: Feb 14 Filed by: PALEKAR ROHAN -3.7%
11/21 Form SC 13D 89bio, Inc. Filed by: Longitude Capital Partners III, LLC -2.3%
4/7 89bio (NASDAQ: ETNB) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -2.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: